Babesia

PRIMAQUINE REVIEW SOME BASICS AND A WARNING. NEVER TAKE PRIMAQUINE, ARAKODA [TAFENOQUINE], OR DAPSON WITHOUT A BLOOD G6PD TEST. IF YOUR BLOOD G6PD IS LOW, YOUR RED BLOOD CELLS CAN BE DESTROYED–“LYSE” OR HEMOLYSIS. G6PD LEVELS MAY VARY AMONG NATIONS. Primaquine revisited six decades after its discovery Primaquine was first synthesized in 1946 in the USA. […]

NEW MALARIA MED: Aablaquine Aablaquine is a combination drug kit marketed in India for the radical treatment of Plasmodium vivax malaria, designed to prevent relapses. It consists of Chloroquine phosphate tablets and Bulaquine capsules. Bulaquine is an 8-aminoquinoline derivative (a synthetic analogue of primaquine) developed by the Central Drug Research Institute (CDRI) that acts on dormant liver-stage parasites. Key Aspects of

In our Babesia 2006 foundation textbook, still ahead of current frozen approaches, we mention tafenoquine as a possible great new option to treat Babesia. And when it was available, wise infection physicians used it for malaria. As the only new malaria drug in 60 years and as a long acting drug it was exceptional. But

Potheni and colleagues mention: Even with the best basic suggested treatment, some will have persistent infections. The debate is between these being living cysts, persisters, and biofilm forms. While others say this is non-living effects of particles or inflammatory changes or many other reasons. I think both are true. And we should note Lyme is